BOSTON - TelAve -- The International Society for Infectious Diseases (ISID) is inviting applications for the position of Editor-in-Chief of the International Journal of Infectious Diseases (IJID), the Society's flagship scientific journal. The appointment will begin July 1, 2026, with a transition period, and full leadership of the journal is expected by October 1, 2026.

The International Journal of Infectious Diseases is a leading peer-reviewed, open-access publication dedicated to advancing research and knowledge in infectious diseases. With a 2024 Impact Factor of 4.3, the journal ranks in the first quartile (Q1) of infectious diseases journals and has established a strong global reputation for publishing high-quality scientific research.

Published monthly by the International Society for Infectious Diseases, IJID disseminates critical findings related to the epidemiology, diagnosis, treatment, and control of infectious diseases, with particular emphasis on diseases affecting under-resourced regions of the world.

More on TelAve News

• Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
• Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
• Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
• 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
• Yoga Retreats, Ecstatic Dance & Spiritual App launched

The journal publishes a broad range of research including:

• Original clinical and laboratory-based research
• Clinical trial reports
• Review articles
• Selected case reports

Through its global network of authors, reviewers, and editors, IJID plays an important role in supporting the international infectious disease community and promoting scientific exchange across regions and disciplines.

Application Process

Applications for the Editor-in-Chief position must be submitted by April 20, 2026.

Virtual interviews will be conducted May 12–14, 2026. The selected Editor-in-Chief will begin reviewing new manuscripts alongside the editorial team starting July 1, 2026, with the full transition into the role expected by October 1, 2026.

View detailed job description: https://isid.org/wp-content/uploads/2026/03/Editor-in-Chief_IJID_Job-Description.pdf

Qualifications

More on TelAve News

• Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
• Simpalm Staffing Services Launched its Refreshed Website for Remote Staffing Services
• Claude Riveloux Review 2026: How the $10B Fund Manager Dispels 'Scam' Rumors Through Education
• Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
• Danholm Collection Launches Boutique Luxury Real Estate Brokerage in Central Florida

The Editor-in-Chief will guide IJID's editorial strategy over the next five to ten years, working closely with the journal's editorial board, ISID leadership, and the publisher.

Candidates should demonstrate:

• A strong record of research and publication in infectious diseases
• A clear strategic vision for the future growth of the journal
• Understanding of the economics and landscape of open-access publishing
• Commitment to collaborative leadership, working with ISID and editors of sister journals (IJID Regions and IJID One Health)
• Commitment to excellence in peer review and diversity, equity, and inclusion
• Significant editorial experience in academic publishing

Application Requirements

Applicants should submit:

• A full Curriculum Vitae (CV) in PDF format
• A two-page letter outlining their vision and goals for IJID (2026–2031)

Applications must be submitted no later than April 20, 2026 at 11:00 PM Eastern Time.

More information about the journal is available at:
https://www.ijidonline.com/

Apply here:
https://app.smartsheet.com/b/form/019ca0cb26e87...